Innoviva (INVA) Gross Profit (QoQ) (2011 - 2025)
Innoviva (INVA) Gross Profit (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - |
| 2 | Nanobiotix | 1,912.31 Bn | 1,912.25 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.15 Bn | 462.36 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.00 Bn | 115.76 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.22 Bn | 61.47 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - |
| 8 | Argenx Se | 55.76 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.70 Bn | 34.69 Bn | 959.66 Mn |
| 10 | Innoviva | 1.61 Bn | 1.01 Bn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 179.03% |
| Jun 30, 2025 | 13.41% |
| Sep 30, 2024 | 156.61% |
| Jun 30, 2024 | 41.44% |
| Sep 30, 2023 | 3,725.21% |
| Jun 30, 2023 | -2,590.69% |
| Sep 30, 2022 | 6,274.29% |
| Jun 30, 2022 | 84.63% |
| Dec 31, 2011 | -16.62% |
| Sep 30, 2011 | 23.39% |